SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-14-005347
Filing Date
2014-11-10
Accepted
2014-11-10 09:15:55
Documents
4
Period of Report
2014-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20141110.htm 8-K 28094
2 EX-99.1 rare-ex99_201411106.htm EX-99 173465
3 GRAPHIC g201411101348146511430.jpg GRAPHIC 375416
4 GRAPHIC g201411101348146201429.jpg GRAPHIC 7170
  Complete submission text file 0001564590-14-005347.txt   730099
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 141206814
SIC: 2834 Pharmaceutical Preparations